Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Viruses|August 10, 2021
Potential Phosphorylation of Viral Nonstructural Protein 1 in Dengue Virus InfectionThanyaporn Dechtawewat, Sittiruk Roytrakul, Yodying Yingchutrakul, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 23, 2024
In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue feverJunjie Ding, Dumrong Mairiang, Dararat Prayongkul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 19, 2021
Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2/3 Randomized Double-blinded Placebo Controlled TrialYupin Suputtamongkol, Panisadee Avirutnan, Dumrong Mairiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?Juthathip Mongkolsapaya, Thaneeya Duangchinda, Wanwisa Dejnirattisai, et al.
ACS Sensors|December 2, 2021
Gravity-Driven Microfluidic Siphons: Fluidic Characterization and Application to Quantitative ImmunoassaysNuno M Reis, Sarah H Needs, Sophie M Jegouic, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Application of One-Step Reverse Transcription Droplet Digital PCR for Dengue Virus Detection and Quantification in Clinical SpecimensDumrong Mairiang, Adisak Songjaeng, Prachya Hansuealueang, et al.
Plos One|August 4, 2025
Prognostic prediction of dengue hemorrhagic fever in pediatric patients with suspected dengue infection: A multi-site studyMyat Su Yin, Peter Haddawy, Panhavath Meth, et al.
Plos One|March 9, 2026
Correction: Prognostic prediction of dengue hemorrhagic fever in pediatric patients with suspected dengue infection: A multi-site studyMyat Su Yin, Peter Haddawy, Panhavath Meth, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 30, 2026
Dengue virus non-structural protein 1 as a surrogate biomarker of antiviral efficacy in early phase clinical trialsVaristha Metem, Dumrong Mairiang, Junjie Ding, et al.
The Journal of Infectious Diseases|March 18, 2006
Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complementPanisadee Avirutnan, Nuntaya Punyadee, Sansanee Noisakran, et al.
Pageof 6